Insider Trading Alert - AEL, SREV And MPW Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 23, 2014, 73 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $62.51 to $8,984,875.00.

Highlighted Stocks Traded by Insiders:

American Equity Investment Life (AEL) - FREE Research Report

Richardson Debra J, who is Executive VP & Secretary at American Equity Investment Life, sold 1,000 shares at $28.65 on Dec. 23, 2014. Following this transaction, the Executive VP & Secretary owned 224,798 shares meaning that the stake was reduced by 0.44% with the 1,000-share transaction.

The shares most recently traded at $28.61, down $0.04, or 0.14% since the insider transaction. Historical insider transactions for American Equity Investment Life go as follows:

  • 4-Week # shares sold: 8,000
  • 12-Week # shares sold: 9,900
  • 24-Week # shares sold: 9,900

The average volume for American Equity Investment Life has been 674,000 shares per day over the past 30 days. American Equity Investment Life has a market cap of $2.1 billion and is part of the financial sector and insurance industry. Shares are up 7.96% year-to-date as of the close of trading on Monday.

American Equity Investment Life Holding Company, through its subsidiaries, operates in the insurance business in 50 states and the District of Columbia. It underwrites fixed annuities, including fixed index annuities and fixed rate annuities, as well as single premium immediate annuities. The stock currently has a dividend yield of 0.71%. The company has a P/E ratio of 15.9. Currently, there is 1 analyst who rates American Equity Investment Life a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AEL - FREE

TheStreet Quant Ratings rates American Equity Investment Life as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full American Equity Investment Life Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

ServiceSource International (SREV) - FREE Research Report

Johnson Ashley F., who is Chief Customer Officer at ServiceSource International, sold 9,615 shares at $4.52 on Dec. 23, 2014. Following this transaction, the Chief Customer Officer owned 264,987 shares meaning that the stake was reduced by 3.5% with the 9,615-share transaction.

The shares most recently traded at $4.52, down $0.00, or 0.06% since the insider transaction. Historical insider transactions for ServiceSource International go as follows:

  • 4-Week # shares bought: 34,700
  • 4-Week # shares sold: 8,500
  • 12-Week # shares bought: 34,700
  • 12-Week # shares sold: 8,500
  • 24-Week # shares bought: 34,700
  • 24-Week # shares sold: 8,500

The average volume for ServiceSource International has been 913,400 shares per day over the past 30 days. ServiceSource International has a market cap of $381.2 million and is part of the technology sector and computer software & services industry. Shares are down 45.23% year-to-date as of the close of trading on Monday.

ServiceSource International, Inc. provides recurring revenue management, maintenance, support, and subscription for technology and technology-enabled healthcare and life sciences companies. Currently, there are 3 analysts who rate ServiceSource International a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SREV - FREE

TheStreet Quant Ratings rates ServiceSource International as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full ServiceSource International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Medical Properties (MPW) - FREE Research Report

McLean Emmett E, who is EVP, Secretary and COO at Medical Properties, sold 120,000 shares at $13.70 on Dec. 23, 2014. Following this transaction, the EVP, Secretary and COO owned 802,111 shares meaning that the stake was reduced by 13.01% with the 120,000-share transaction.

The shares most recently traded at $13.75, up $0.05, or 0.36% since the insider transaction. Historical insider transactions for Medical Properties go as follows:

  • 4-Week # shares sold: 45,360
  • 12-Week # shares sold: 45,360
  • 24-Week # shares sold: 75,360

The average volume for Medical Properties has been 1.4 million shares per day over the past 30 days. Medical Properties has a market cap of $2.3 billion and is part of the financial sector and real estate industry. Shares are up 13.18% year-to-date as of the close of trading on Monday.

Medical Properties Trust, Inc. operates as a real estate investment trust (REIT) in the United States. It acquires, develops, and invests in healthcare facilities; and leases healthcare facilities to healthcare operating companies and healthcare providers. The stock currently has a dividend yield of 6.23%. The company has a P/E ratio of 46.5. Currently, there are 3 analysts who rate Medical Properties a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MPW - FREE

TheStreet Quant Ratings rates Medical Properties as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, reasonable valuation levels, increase in stock price during the past year, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Medical Properties Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices